Showing results (21-30 of 183) with videos related to
Sort By:
Pageof 19
Frontiers in Oncology|December 19, 2022
KRAS G12D targeted therapies for pancreatic cancer: Has the fortress been conquered?Sahar F Bannoura, Husain Yar Khan, Asfar S AzmiToxicology and Applied Pharmacology|January 9, 2007
Prooxidant DNA breakage induced by caffeic acid in human peripheral lymphocytes: involvement of endogenous copper and a putative mechanism for anticancer propertiesS H Bhat, A S Azmi, S M HadiDrug Discovery Today|June 23, 2020
Exportin 1 inhibition as antiviral therapyMd Hafiz Uddin, Jeffrey A Zonder, Asfar S AzmiClinical and Translational Medicine|February 2, 2013
Network insights on oxaliplatin anti-cancer mechanismsOsama M Alian, Asfar S Azmi, Ramzi M MohammadThe American Journal of Pathology|December 19, 2018
miRNA and Gene Expression in Pancreatic Ductal AdenocarcinomaAnteneh A Tesfaye, Asfar S Azmi, Philip A PhilipF1000Research|December 24, 2013
Pro-oxidant activity of dietary chemopreventive agents: an under-appreciated anti-cancer propertyAsfar S Azmi, Fazlul H Sarkar, S M HadiCancer Letters|January 1, 1997
Adriamycin induces apoptosis in rat thymocytesS Azmi, L Bhatia, N Khanna, et al.Recent Patents on Cardiovascular Drug Discovery|February 4, 2012
A(3) adenosine receptor: a plausible therapeutic target for cardio-protection in diabetesShamama Nishat, Hiba Shabir, Asfar S Azmi, et al.Mutation Research|March 10, 2001
Differential sensitivity of murine myeloid FDC-P1 cells and apoptosis resistant mutant(s) to anticancer drugsN Singh, S Azmi, A Sheriff, et al.Current Pharmaceutical Design|March 28, 2013
Systems biology approaches to pancreatic cancer detection, prevention and treatmentOsama M Alian, Philip A Philip, Fazlul H Sarkar, et al.Pageof 19